Combination treatment with metformin and glibenclamide versus single-drug therapies in type 2 diabetes mellitus: a randomized, double-blind, comparative study. | Metabolism;52(7): 862-7, 2003 Jul. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Combination treatment with metformin and glibenclamide versus single-drug therapies in type 2 diabetes mellitus: a randomized, double-blind, comparative study.

Tosi, Flavia; Muggeo, Michele; Brun, Elisabetta; Spiazzi, Giovanna; Perobelli, Laura; Zanolin, Elisabetta; Gori, Mario; Coppini, Alessandro; Moghetti, Paolo.

Affiliation

Tosi F; Division of Endocrinology and Metabolic Diseases, University of Verona, Italy.

Metabolism ; 52(7): 862-7, 2003 Jul.

Article in En | MEDLINE | ID: mdl-12870162

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Glyburide / Diabetes Mellitus, Type 2 / Hypoglycemic Agents / Metformin Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Metabolism Year: 2003 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Glyburide / Diabetes Mellitus, Type 2 / Hypoglycemic Agents / Metformin Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Metabolism Year: 2003 Document type: Article Affiliation country: Country of publication: